581 related articles for article (PubMed ID: 16316970)
61. Thrombolysis and neuroprotection in cerebral ischemia.
Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM
Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822
[TBL] [Abstract][Full Text] [Related]
62. Map-ISODATA demarcates regional response to combination rt-PA and 7E3 F(ab')2 treatment of embolic stroke in the rat.
Li L; Jiang Q; Ding G; Zhang L; Zhang ZG; Ewing JR; Knight RA; Kapke A; Soltanian-Zadeh H; Chopp M
J Magn Reson Imaging; 2005 Jun; 21(6):726-34. PubMed ID: 15906325
[TBL] [Abstract][Full Text] [Related]
63. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke.
Guo M; Cox B; Mahale S; Davis W; Carranza A; Hayes K; Sprague S; Jimenez D; Ding Y
Neuroscience; 2008 Jan; 151(2):340-51. PubMed ID: 18160227
[TBL] [Abstract][Full Text] [Related]
64. Magnetic resonance angiography of thromboembolic stroke in rats: indicator of recanalization probability and tissue survival after recombinant tissue plasminogen activator treatment.
Hilger T; Niessen F; Diedenhofen M; Hossmann KA; Hoehn M
J Cereb Blood Flow Metab; 2002 Jun; 22(6):652-62. PubMed ID: 12045663
[TBL] [Abstract][Full Text] [Related]
65. Functional recovery after embolic stroke in rodents by activated protein C.
Zlokovic BV; Zhang C; Liu D; Fernandez J; Griffin JH; Chopp M
Ann Neurol; 2005 Sep; 58(3):474-7. PubMed ID: 16130108
[TBL] [Abstract][Full Text] [Related]
66. Analysis of combined treatment of embolic stroke in rat with r-tPA and a GPIIb/IIIa inhibitor.
Ding G; Jiang Q; Zhang L; Zhang ZG; Li L; Knight RA; Ewing JR; Wang Y; Chopp M
J Cereb Blood Flow Metab; 2005 Jan; 25(1):87-97. PubMed ID: 15678115
[TBL] [Abstract][Full Text] [Related]
67. Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration.
Buttmann M; Lorenz A; Weishaupt A; Rieckmann P
J Neurochem; 2007 Aug; 102(4):1001-8. PubMed ID: 17442054
[TBL] [Abstract][Full Text] [Related]
68. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.
Copin JC; Gasche Y
Brain Res; 2008 Dec; 1243():161-6. PubMed ID: 18835259
[TBL] [Abstract][Full Text] [Related]
69. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
[TBL] [Abstract][Full Text] [Related]
70. Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.
Allahtavakoli M; Shabanzadeh A; Roohbakhsh A; Pourshanazari A
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):309-14. PubMed ID: 17910613
[TBL] [Abstract][Full Text] [Related]
71. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat.
Dohare P; Garg P; Jain V; Nath C; Ray M
Behav Brain Res; 2008 Nov; 193(2):289-97. PubMed ID: 18611416
[TBL] [Abstract][Full Text] [Related]
72. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
[TBL] [Abstract][Full Text] [Related]
73. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
[TBL] [Abstract][Full Text] [Related]
74. Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model.
Henninger N; Bratane BT; Bastan B; Bouley J; Fisher M
J Cereb Blood Flow Metab; 2009 Jan; 29(1):119-29. PubMed ID: 18766195
[TBL] [Abstract][Full Text] [Related]
75. Vepoloxamer Enhances Fibrinolysis of tPA (Tissue-Type Plasminogen Activator) on Acute Ischemic Stroke.
Wang C; Huang R; Li C; Lu M; Emanuele M; Zhang ZG; Chopp M; Zhang L
Stroke; 2019 Dec; 50(12):3600-3608. PubMed ID: 31587657
[TBL] [Abstract][Full Text] [Related]
76. Pial microvascular responses to transient bilateral common carotid artery occlusion: effects of hypertonic glycerol.
Lapi D; Marchiafava PL; Colantuoni A
J Vasc Res; 2008; 45(2):89-102. PubMed ID: 17934320
[TBL] [Abstract][Full Text] [Related]
77. Endothelial nitric oxide synthase pathophysiology after nonocclusive common carotid artery thrombosis in rats.
Danton GH; Prado R; Truettner J; Watson BD; Dietrich WD
J Cereb Blood Flow Metab; 2002 May; 22(5):612-9. PubMed ID: 11973434
[TBL] [Abstract][Full Text] [Related]
78. Statin treatment and 3' polyadenylation of eNOS mRNA.
Kosmidou I; Moore JP; Weber M; Searles CD
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2642-9. PubMed ID: 17916773
[TBL] [Abstract][Full Text] [Related]
79. Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat.
Veldhuis WB; Derksen JW; Floris S; Van Der Meide PH; De Vries HE; Schepers J; Vos IM; Dijkstra CD; Kappelle LJ; Nicolay K; Bär PR
J Cereb Blood Flow Metab; 2003 Sep; 23(9):1029-39. PubMed ID: 12973019
[TBL] [Abstract][Full Text] [Related]
80. Thrombolytic therapy in experimental embolic stroke.
Overgaard K
Cerebrovasc Brain Metab Rev; 1994; 6(3):257-86. PubMed ID: 7811566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
